BRIEF-Aptose Biosciences Reports Qtrly Loss Per Share $0.17
BRIEF-Aptose Biosciences Reports Qtrly Loss Per Share $0.17
March 23 (Reuters) - Aptose Biosciences Inc APS.TO :
* APTOSE REPORTS RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2020
* APTOSE BIOSCIENCES INC - ANNOUNCES RESIGNATION OF CFO GREGORY CHOW
* APTOSE BIOSCIENCES INC - QTRLY LOSS PER SHARE $0.17
* APTOSE BIOSCIENCES INC - TOTAL CASH AND CASH EQUIVALENTS AND INVESTMENTS AS OF DECEMBER 31, 2020 WERE $122.4 MILLION
* APTOSE BIOSCIENCES - EXPECTS CASH ON HAND, AVAILABLE CAPITAL PROVIDE CO WITH SUFFICIENT RESOURCES TO FUND OPERATIONS INTO H1 2023
Source text for Eikon: Further company coverage:
March 23 (Reuters) - Aptose Biosciences Inc APS.TO :
路透3月23日電-Aptose生物科學公司APS.TO：
* APTOSE REPORTS RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2020
*Aptose報告2020年第四季度和全年業績
* APTOSE BIOSCIENCES INC - ANNOUNCES RESIGNATION OF CFO GREGORY CHOW
*Aptose Biosciences Inc-宣佈CFO Gregory Chow辭職
* APTOSE BIOSCIENCES INC - QTRLY LOSS PER SHARE $0.17
*Aptose Biosciences Inc-每股季度虧損0.17美元
* APTOSE BIOSCIENCES INC - TOTAL CASH AND CASH EQUIVALENTS AND INVESTMENTS AS OF DECEMBER 31, 2020 WERE $122.4 MILLION
*Aptose Biosciences Inc-截至2020年12月31日，現金和現金等價物以及投資總額為1.224億美元
* APTOSE BIOSCIENCES - EXPECTS CASH ON HAND, AVAILABLE CAPITAL PROVIDE CO WITH SUFFICIENT RESOURCES TO FUND OPERATIONS INTO H1 2023
*Aptose Biosciences-預計手頭有現金，可用資金為CO提供足夠的資源，為2023年上半年的運營提供資金
Source text for Eikon: Further company coverage:
Eikon的源文本：進一步的公司報道：
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧